Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2344) 2344
Publication (287) 287
Newspaper Article (46) 46
Book Review (24) 24
Book Chapter (16) 16
Dissertation (5) 5
Book / eBook (3) 3
Conference Proceeding (3) 3
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1387) 1387
index medicus (1266) 1266
chemokines (1188) 1188
male (855) 855
immunology (828) 828
female (805) 805
cytokines (794) 794
animals (787) 787
neurosciences (771) 771
inflammation (735) 735
cerebrospinal-fluid (722) 722
central-nervous-system (608) 608
adult (519) 519
middle aged (488) 488
mice (442) 442
research (441) 441
expression (383) 383
brain (380) 380
cerebrospinal fluid (374) 374
multiple sclerosis (373) 373
neurology (345) 345
proteins (326) 326
clinical neurology (314) 314
medicine (309) 309
research article (307) 307
aged (275) 275
infectious diseases (264) 264
experimental autoimmune encephalomyelitis (263) 263
disease (259) 259
chemokine (255) 255
health aspects (253) 253
multiple-sclerosis (250) 250
gene expression (237) 237
nervous system (231) 231
rodents (228) 228
multidisciplinary sciences (227) 227
pathogenesis (227) 227
science (227) 227
central nervous system (225) 225
cells, cultured (224) 224
chemokine receptors (221) 221
immune system (217) 217
lymphocytes (215) 215
analysis (212) 212
infections (211) 211
biomarkers (210) 210
cell biology (207) 207
monocyte chemoattractant protein-1 (204) 204
physiological aspects (202) 202
t-cells (202) 202
disease models, animal (195) 195
enzyme-linked immunosorbent assay (193) 193
mice, inbred c57bl (190) 190
microglia (186) 186
rats (185) 185
studies (183) 183
adolescent (171) 171
article (169) 169
immune response (168) 168
virology (166) 166
infection (165) 165
macrophages (165) 165
pathology (164) 164
genetic aspects (163) 163
blood-brain barrier (161) 161
hiv (158) 158
care and treatment (157) 157
cells (155) 155
necrosis-factor-alpha (152) 152
development and progression (151) 151
biology (150) 150
chemokines - metabolism (150) 150
flow cytometry (150) 150
activation (147) 147
blood-brain-barrier (147) 147
cytokines - metabolism (147) 147
risk factors (146) 146
biomarkers - cerebrospinal fluid (145) 145
diagnosis (145) 145
apoptosis (144) 144
cytokine (143) 143
neuroinflammation (143) 143
ligands (141) 141
young adult (141) 141
encephalitis (139) 139
dendritic cells (135) 135
child (132) 132
microbiology (132) 132
meningitis (131) 131
brain - pathology (130) 130
case-control studies (130) 130
patients (128) 128
lymphocytes t (125) 125
monocyte chemoattractant protein 1 (125) 125
t cells (125) 125
astrocytes (124) 124
neurons (123) 123
tumor-necrosis-factor (122) 122
medical research (118) 118
multiple sclerosis - immunology (118) 118
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2382) 2382
German (8) 8
Polish (6) 6
Czech (3) 3
Japanese (3) 3
Portuguese (2) 2
Spanish (2) 2
Chinese (1) 1
Dutch (1) 1
French (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
by Shi, Min and Bradner, Joshua and Hancock, Aneeka M and Chung, Kathryn A and Quinn, Joseph F and Peskind, Elaine R and Galasko, Douglas and Jankovic, Joseph and Zabetian, Cyrus P and Kim, Hojoong M and Leverenz, James B and Montine, Thomas J and Ginghina, Carmen and Kang, Un Jung and Cain, Kevin C and Wang, Yu and Aasly, Jan and Goldstein, David and Zhang, Jing
Annals of Neurology, ISSN 0364-5134, 03/2011, Volume 69, Issue 3, pp. 570 - 580
Objective: There is a clear need to develop biomarkers for Parkinson disease (PD) diagnosis, differential diagnosis of Parkinsonian disorders, and monitoring... 
TAU-PROTEIN | MULTIPLE SYSTEM ATROPHY | DEMENTIA | MICROGLIA | ALZHEIMERS-DISEASE | INFLAMMATION | CSF | ALPHA-SYNUCLEIN | FRACTALKINE-RECEPTOR | NEUROSCIENCES | LEWY BODIES | CLINICAL NEUROLOGY | Severity of Illness Index | Diagnosis, Differential | Phosphorylation | Peptide Fragments - cerebrospinal fluid | Intracellular Signaling Peptides and Proteins - cerebrospinal fluid | Humans | Chemokine CX3CL1 - cerebrospinal fluid | tau Proteins - cerebrospinal fluid | fms-Like Tyrosine Kinase 3 - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Disease Progression | Alzheimer Disease - diagnosis | Protein Deglycase DJ-1 | Multiple System Atrophy - cerebrospinal fluid | alpha-Synuclein - cerebrospinal fluid | Analysis of Variance | Parkinson Disease - cerebrospinal fluid | Sensitivity and Specificity | Amyloid beta-Peptides - cerebrospinal fluid | Parkinson Disease - diagnosis | ROC Curve | Biomarkers - cerebrospinal fluid | Multiple System Atrophy - diagnosis | Oncogene Proteins - cerebrospinal fluid | Biomarkers | Ligands | Parkinsons disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment
by Lindqvist, Daniel and Hall, Sara and Surova, Yulia and Nielsen, Henrietta M and Janelidze, Shorena and Brundin, Lena and Hansson, Oskar and Klinisk minnesforskning and Lund University and Psychiatry (Lund) and Neurologi, Lund and MultiPark: Multidisciplinary research focused on Parkinson´s disease and Psykiatri, Lund and Clinical Memory Research and Lunds universitet and Neurology, Lund
Brain, Behavior, and Immunity, ISSN 0889-1591, 10/2013, Volume 33, Issue Jul.,31, pp. 183 - 189
Neuroinflammation may be involved in the pathophysiology of Parkinson's disease (PD) and specifically in non-motor symptoms such as depression, fatigue and... 
C-reactive protein | Parkinson's disease | Cytokines | Depression | Fatigue | Neuroinflammation | Cerebrospinal fluid | Dementia | TREATMENT-RESISTANT DEPRESSION | ALZHEIMERS-DISEASE | MAJOR DEPRESSION | IMMUNOLOGY | FACTOR ANTAGONIST INFLIXIMAB | NEUROSCIENCES | NONMOTOR SYMPTOMS | TNF-ALPHA | DIAGNOSTIC-CRITERIA | BRAIN | Humans | Middle Aged | Fatigue - complications | Dementia - diagnosis | Male | Chemokine CCL26 | Chemokines, CC - cerebrospinal fluid | Chemokine CCL2 - cerebrospinal fluid | Inflammation Mediators - cerebrospinal fluid | Depression - cerebrospinal fluid | Parkinson Disease - cerebrospinal fluid | Dementia - cerebrospinal fluid | Depression - complications | Female | Interleukin-6 - cerebrospinal fluid | Cognition Disorders - cerebrospinal fluid | Parkinson Disease - complications | Chemokine CCL11 - cerebrospinal fluid | Chemokine CCL3 - cerebrospinal fluid | Tumor Necrosis Factor-alpha - cerebrospinal fluid | C-Reactive Protein - cerebrospinal fluid | Chemokine CCL4 - cerebrospinal fluid | Cognition Disorders - complications | Dementia - complications | Fatigue - cerebrospinal fluid | Parkinson Disease - diagnosis | Aged | Chemokine CCL24 - cerebrospinal fluid | Depression, Mental | Diagnosis | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury
by Kwon, Brian K and Stammers, Anthea M.T and Belanger, Lise M and Bernardo, Arlene and Chan, Donna and Bishop, Carole M and Slobogean, Gerard P and Zhang, Hongbin and Umedaly, Hamed and Giffin, Mitch and Street, John and Boyd, Michael C and Paquette, Scott J and Fisher, Charles G and Dvorak, Marcel F
Journal of Neurotrauma, ISSN 0897-7151, 04/2010, Volume 27, Issue 4, pp. 669 - 682
There is an urgent need for both the scientific development and clinical validation of novel therapies for acute spinal cord injury (SCI). The scientific... 
Traumatic spinal cord injury | Biomarkers | Clinical trial | Inflammation | Cerebrospinal fluid | clinical trial | FUNCTIONAL RECOVERY | RAT | biomarkers | LEVEL NEUROPATHIC PAIN | TISSUE-DAMAGE | NEUROSCIENCES | CLINICAL NEUROLOGY | traumatic spinal cord injury | TUMOR-NECROSIS-FACTOR | inflammation | GM-CSF | cerebrospinal fluid | CLINICAL-TRIALS | CONTUSION INJURY | ICCP PANEL | DECREASES SECONDARY DEGENERATION | CRITICAL CARE MEDICINE | Predictive Value of Tests | Prospective Studies | Cytokines - analysis | Humans | Middle Aged | Interleukin-8 - cerebrospinal fluid | Male | Young Adult | Chemokine CCL2 - cerebrospinal fluid | Inflammation Mediators - cerebrospinal fluid | Inflammation Mediators - analysis | Myelitis - immunology | Recovery of Function - physiology | Nerve Growth Factors - cerebrospinal fluid | Interleukin-6 - cerebrospinal fluid | S100 Calcium Binding Protein beta Subunit | Myelitis - physiopathology | Biomarkers - analysis | Biomarkers - blood | Myelitis - cerebrospinal fluid | Trauma Severity Indices | Chemokine CCL2 - blood | Cytokines - cerebrospinal fluid | S100 Proteins - analysis | tau Proteins - blood | Spinal Cord - immunology | Spinal Cord - physiopathology | Biomarkers - cerebrospinal fluid | Chemokine CCL2 - analysis | Interleukin-6 - analysis | Prognosis | Spinal Cord - metabolism | Glial Fibrillary Acidic Protein - cerebrospinal fluid | Interleukin-6 - blood | S100 Proteins - blood | Adult | Female | Nerve Growth Factors - blood | Interleukin-8 - blood | Cytokines - blood | Enzyme-Linked Immunosorbent Assay | Glial Fibrillary Acidic Protein - analysis | S100 Proteins - cerebrospinal fluid | tau Proteins - cerebrospinal fluid | Interleukin-8 - analysis | Nerve Growth Factors - analysis | Glial Fibrillary Acidic Protein - blood | Spinal Cord Injuries - physiopathology | tau Proteins - analysis | Spinal Cord Injuries - diagnosis | Spinal Cord Injuries - cerebrospinal fluid | Care and treatment | Patient outcomes | Physiological aspects | Spinal cord injuries | Diagnosis | Biological markers | Cerebrospinal fluid proteins | Body fluids | Cytokines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid
by Schläger, Christian and Körner, Henrike and Krueger, Martin and Vidoli, Stefano and Haberl, Michael and Mielke, Dorothee and Brylla, Elke and Issekutz, Thomas and Cabanãs, Carlos and Nelson, Peter J and Ziemssen, Tjalf and Rohde, Veit and Bechmann, Ingo and Lodygin, Dmitri and Odoardi, Francesca and Flügel, Alexander
Nature, ISSN 0028-0836, 02/2016, Volume 530, Issue 7590, pp. 349 - 353
In multiple sclerosis, brain-reactive T cells invade the central nervous system (CNS) and induce a self-destructive inflammatory process. T-cell infiltrates... 
MIGRATION | CNS LESIONS | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | ACTIVATION | MULTIPLE-SCLEROSIS | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | IN-VIVO | CENTRAL-NERVOUS-SYSTEM | CHOROID-PLEXUS | REAL-TIME | Integrin alpha4beta1 - metabolism | Meninges - immunology | Rats, Inbred Lew | Encephalomyelitis, Autoimmune, Experimental - immunology | Lymphocyte Function-Associated Antigen-1 - metabolism | Male | Adoptive Transfer | Cerebrospinal Fluid - cytology | Cerebrospinal Fluid - immunology | Receptors, CCR5 - metabolism | Female | Choroid Plexus | T-Lymphocytes - pathology | Macrophages - immunology | Disease Models, Animal | Receptors, CXCR3 - metabolism | Encephalomyelitis, Autoimmune, Experimental - pathology | Meninges - pathology | Lymphocyte Activation | Rats | Cell Adhesion | Collagen - metabolism | Macrophages - metabolism | Animals | Multiple Sclerosis - immunology | Multiple Sclerosis - pathology | T-Lymphocytes - immunology | Chemokines - metabolism | Cell Movement | Complications and side effects | Care and treatment | Influence | Meningitis | Research | Cerebrospinal fluid | T cells | Antigens | Body fluids | Spinal cord | Cytokines | Microscopy | Lymphocytes | T cell receptors | Inflammation | Gene expression | Chemokines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
by Matsushita, Takuya and Tateishi, Takahisa and Isobe, Noriko and Yonekawa, Tomomi and Yamasaki, Ryo and Matsuse, Dai and Murai, Hiroyuki and Kira, Jun-Ichi
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e61835
Background: Differences in cytokine/chemokine profiles among patients with neuromyelitis optica (NMO), relapsing remitting multiple sclerosis (RRMS), and... 
RHEUMATOID-ARTHRITIS | CELLS | MESSENGER-RNA | MARKER | INFLAMMATION | MS | MULTIDISCIPLINARY SCIENCES | DISTINCT | T-HELPER TYPE-1 | DIAGNOSTIC-CRITERIA | SYNOVIAL-FLUIDS | Multiple Sclerosis, Chronic Progressive - cerebrospinal fluid | Recurrence | Aquaporin 4 - immunology | Chemokines - cerebrospinal fluid | Humans | Middle Aged | Male | Granulocyte-Macrophage Colony-Stimulating Factor - cerebrospinal fluid | Cytokines - cerebrospinal fluid | Interleukin-17 - cerebrospinal fluid | Neuromyelitis Optica - cerebrospinal fluid | Adult | Female | Interleukin-6 - cerebrospinal fluid | Multiple Sclerosis, Relapsing-Remitting - cerebrospinal fluid | Development and progression | Neuromyelitis optica | Interleukins | T cells | Multiplexing | Neuroimaging | Immunoassay | Multiple sclerosis | Spinal cord | Disease | Carbon tetrachloride | Correlation coefficients | Interleukin | Central nervous system | Helper cells | Fluorescence | Lymphocytes T | Cerebrospinal fluid | Macrophages | Interleukin 6 | Proteins | Granulocyte colony-stimulating factor | Lymphocytes | Quality | Measurement methods | Colony-stimulating factor | Differential diagnosis | Growth factors | Immunoglobulins | Medical imaging | Psoriasis | Cytokines | Granulocyte-macrophage colony-stimulating factor | Colonies | Aquaporins | Neutrophils | CCL4 protein | Patients | Microglia | Neurological diseases | Neurology | Overexpression | Neuromyelitis | γ-Interferon | CXCL10 protein | Interferon | Chemokines | Monocyte chemoattractant protein 1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection
by Kamat, Anupa and Lyons, Jennifer L and Misra, Vikas and Uno, Hajime and Morgello, Susan and Singer, Elyse J and Gabuzda, Dana
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 07/2012, Volume 60, Issue 3, pp. 234 - 243
BACKGROUND:Activated monocytes/macrophages play a role in severe forms of HIV-associated neurocognitive disorders (HAND), but little is known about the... 
HIV | biomarkers | cerebrospinal fluid | HIV-associated neurocognitive disorders | immune activation | INFECTIOUS DISEASES | HEPATITIS-C INFECTION | CHEMOKINE CONCENTRATIONS | CHEMOTACTIC PROTEIN-1 | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 INFECTION | INTERFERON-GAMMA | ACTIVE ANTIRETROVIRAL THERAPY | CENTRAL-NERVOUS-SYSTEM | AIDS DEMENTIA | Chemokines - blood | Lipopolysaccharide Receptors - cerebrospinal fluid | Humans | Middle Aged | Male | RNA, Viral - blood | Cognition | Monocytes - immunology | Case-Control Studies | Viral Load | Chemokine CCL2 - cerebrospinal fluid | Interleukin-6 - blood | Adult | Female | AIDS Dementia Complex - virology | Interleukin-6 - cerebrospinal fluid | Cytokines - blood | AIDS Dementia Complex - psychology | Chemokines - cerebrospinal fluid | AIDS Dementia Complex - cerebrospinal fluid | Biomarkers - blood | Chemokine CCL2 - blood | Cytokines - cerebrospinal fluid | AIDS Dementia Complex - immunology | Lipopolysaccharide Receptors - blood | Neuropsychological Tests | Biomarkers - cerebrospinal fluid
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Cerebrospinal fluid cytokines in Lyme neuroborreliosis
by Pietikäinen, Annukka and Maksimow, Mikael and Kauko, Tommi and Hurme, Saija and Salmi, Marko and Hytönen, Jukka
Journal of Neuroinflammation, ISSN 1742-2094, 10/2016, Volume 13, Issue 1, p. 273
Background: Lyme neuroborreliosis (LNB) is one of the manifestations of Lyme disease. Although it is known that immune reaction of LNB patients is dominated by... 
Lyme disease | Cytokine profiling | Borrelia | CXCL13 | Neuroborreliosis | BORRELIA-BURGDORFERI | DIAGNOSIS | MANAGEMENT | INTERLEUKIN-10 | IMMUNOLOGY | NEUROSCIENCES | PATHOGENESIS | TICK-BORNE ENCEPHALITIS | INFLAMMATION | LYMPHOMA | INFECTION | CHEMOKINE CXCL13 | Enzyme-Linked Immunosorbent Assay | Multiple Sclerosis - cerebrospinal fluid | Humans | Middle Aged | Child, Preschool | Male | Cytokines - cerebrospinal fluid | Lyme Neuroborreliosis - cerebrospinal fluid | Young Adult | Adolescent | Statistics, Nonparametric | Aged, 80 and over | Adult | Female | Aged | Child | Viral antibodies | Encephalitis | Multiple sclerosis | Cytokines | Analysis | Antibodies | Inflammation | B cells | Diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Immunophenotyping of Cerebrospinal Fluid Cells in Multiple Sclerosis: In Search of Biomarkers
by Alvermann, Sascha and Hennig, Christian and Stüve, Olaf and Wiendl, Heinz and Stangel, Martin
JAMA Neurology, ISSN 2168-6149, 07/2014, Volume 71, Issue 7, pp. 905 - 912
IMPORTANCE: Cerebrospinal fluid (CSF) is the compartment in closest proximity to the central nervous system (CNS) parenchyma and might reflect immune pathology... 
B-CELLS | NATURAL-KILLER-CELLS | DENDRITIC CELLS | IMMUNE SURVEILLANCE | REGULATORY T-CELLS | CNS | CENTRAL-NERVOUS-SYSTEM | CHOROID-PLEXUS | CHEMOKINE RECEPTORS | CLINICAL NEUROLOGY | LYMPHOCYTES | Multiple Sclerosis - immunology | Multiple Sclerosis - pathology | Immunophenotyping - methods | Biomarkers - cerebrospinal fluid | Multiple Sclerosis - cerebrospinal fluid | Humans
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Cerebrospinal fluid chemokine patterns in children with enterovirus 71-related encephalitis
by Liu, Jinling and Li, Shuxian and Cai, Chunyan and Xu, Yingchun and Jiang, Yuan and Chen, Zhimin
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 1658 - 9
Enterovirus 71 (EV71) is a major pathogen that causes hand, foot and mouth disease (HFMD) as well as neurological complications, such as encephalitis. The... 
INFECTIONS | ROLES | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | DISEASE | ANTIBODY | BRAIN-STEM ENCEPHALITIS | MICE | EXPRESSION | Seizures, Febrile - diagnosis | Diagnosis, Differential | Enterovirus Infections - diagnosis | Encephalitis, Viral - virology | Cytokines - analysis | Humans | Child, Preschool | Infant | Male | Seizures, Febrile - pathology | Enterovirus A, Human - isolation & purification | Enterovirus Infections - virology | Cerebrospinal Fluid - chemistry | Female | ROC Curve | Encephalitis, Viral - pathology | Enterovirus Infections - pathology | Child | Encephalitis | Leukocyte migration | RANTES | Central nervous system | Hand-foot-and-mouth disease | Cerebrospinal fluid | Convalescence | Infectious diseases | Neurological complications | IP-10 protein | Foot-and-mouth disease | Children | Chemokines | Monocyte chemoattractant protein 1 | Interleukin 8
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The inflammatory marker YKL-40 is elevated in cerebrospinal fluid from patients with Alzheimer's but not Parkinson's disease or dementia with Lewy bodies
by Wennström, Malin and Surova, Yulia and Hall, Sara and Nilsson, Christer and Minthon, Lennart and Hansson, Oskar and Nielsen, Henrietta M and Klinisk minnesforskning and Lund University and Neurologi, Lund and MultiPark: Multidisciplinary research focused on Parkinson´s disease and Clinical Memory Research and Lunds universitet and Neurology, Lund
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0135458
A major difference in the revised diagnostic criteria for Alzheimer's disease (AD) is the incorporation of biomarkers to support a clinical diagnosis and allow... 
BIOMARKERS | NATIONAL INSTITUTE | RECOMMENDATIONS | FIBRILLARY ACIDIC PROTEIN | MULTIDISCIPLINARY SCIENCES | DIAGNOSTIC GUIDELINES | MILD COGNITIVE IMPAIRMENT | NF-KAPPA-B | EXPRESSION | ASTROCYTES | ASSOCIATION WORKGROUPS | Lectins - cerebrospinal fluid | Age Factors | Lewy Body Disease - immunology | Chemokines - cerebrospinal fluid | Parkinson Disease - immunology | Humans | Nerve Tissue Proteins - cerebrospinal fluid | Adipokines - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Chitinase-3-Like Protein 1 | Parkinson Disease - cerebrospinal fluid | Dementia - cerebrospinal fluid | Lewy Body Disease - cerebrospinal fluid | Biomarkers - cerebrospinal fluid | Alzheimer Disease - immunology | Dementia - immunology | Biological response modifiers | Intermediate filament proteins | Alzheimer's disease | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
by Novakova, Lenka and Axelsson, Markus and Khademi, Mohsen and Zetterberg, Henrik and Blennow, Kaj and Malmeström, Clas and Piehl, Fredrik and Olsson, Tomas and Lycke, Jan and Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap and Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi and Göteborgs universitet and Gothenburg University and Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry and Sahlgrenska Academy and Sahlgrenska akademin and Institute of Neuroscience and Physiology, Department of Clinical Neuroscience
Multiple Sclerosis Journal, ISSN 1352-4585, 1/2017, Volume 23, Issue 1, pp. 62 - 71
Background: The disease-modifying therapies (DMTs) in relapsing-remitting multiple sclerosis (RRMS) vary in their mode of action and when therapies are... 
Multiple sclerosis | biomarkers | fingolimod | treatment response | cerebrospinal fluid | MARKER | MS | SUBGROUP ANALYSES | NEUROSCIENCES | CLINICAL NEUROLOGY | FIBRILLARY ACIDIC PROTEIN | DISEASE | DOUBLE-BLIND | DISABILITY | CCL2 | CHITOTRIOSIDASE | CSF LEVELS | Enzyme-Linked Immunosorbent Assay - methods | Multiple Sclerosis - cerebrospinal fluid | Humans | Middle Aged | Inflammation - cerebrospinal fluid | Male | Treatment Outcome | Disease Progression | Fingolimod Hydrochloride - cerebrospinal fluid | Glial Fibrillary Acidic Protein - cerebrospinal fluid | Neurofilament Proteins - cerebrospinal fluid | Young Adult | Adult | Female | Biomarkers - cerebrospinal fluid | Chemokine CXCL13 - cerebrospinal fluid | Fingolimod Hydrochloride - therapeutic use | Multiple Sclerosis - drug therapy | Chitinase | Glial fibrillary acidic protein | Neurogranin | CXCL13 protein | Inflammation | Cerebrospinal fluid | Neuronal-glial interactions | Proteins | Immunotherapy | Spectrofluorometry | Biomarkers | Degeneration | Chemokines | Monocyte chemoattractant protein 1 | Enzyme-linked immunosorbent assay | Neurosciences | Neurovetenskaper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children
by Armah, Henry B and Wilson, Nana O and Sarfo, Bismark Y and Powell, Michael D and Bond, Vincent C and Anderson, Winston and Adjei, Andrew A and Gyasi, Richard K and Tettey, Yao and Wiredu, Edwin K and Tongren, Jon Eric and Udhayakumar, Venkatachalam and Stiles, Jonathan K
Malaria Journal, ISSN 1475-2875, 2007, Volume 6, Issue 1, pp. 147 - 147
Background: Plasmodium falciparum can cause a diffuse encephalopathy known as cerebral malaria (CM), a major contributor to malaria associated mortality.... 
CELLS | INFECTIOUS DISEASES | INDUCIBLE PROTEIN-10 | NECROSIS-FACTOR-ALPHA | PLASMODIUM-FALCIPARUM MALARIA | BLOOD-BRAIN-BARRIER | TROPICAL MEDICINE | INTERFERON | IN-VIVO | UNCOMPLICATED MALARIA | TNF-ALPHA | PARASITOLOGY | SOLUBLE FAS LIGAND | Chemokine CCL5 - cerebrospinal fluid | Malaria, Cerebral - cerebrospinal fluid | Immunoassay | Prognosis | Chemokines, CC - blood | Interleukin 1 Receptor Antagonist Protein - cerebrospinal fluid | Humans | Tumor Necrosis Factor-alpha - blood | Fas Ligand Protein - blood | Child, Preschool | E-Selectin - blood | Fas Ligand Protein - cerebrospinal fluid | Infant | Interleukin-8 - cerebrospinal fluid | Male | Malaria, Cerebral - mortality | Chemokines, CC - cerebrospinal fluid | Interleukin 1 Receptor Antagonist Protein - blood | Chemokine CCL5 - blood | Female | Interleukin-8 - blood | Child | Chemokine CXCL10 - cerebrospinal fluid | Chemokine CXCL10 - blood | Enzyme-Linked Immunosorbent Assay | Tumor Necrosis Factor-alpha - cerebrospinal fluid | Survival Rate | Ghana | Biomarkers - blood | Malaria, Cerebral - blood | E-Selectin - cerebrospinal fluid | Biomarkers - cerebrospinal fluid | Serum | Research | Cerebrospinal fluid | Malaria | Health aspects | Patient outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights